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Plasmids have been known to play a major role in the dissemination of antibiotics resistance genes in a 
microbial population. In this background, 148 Proteus species comprising of 97 Proteus mirabilis and 
51 Proteus vulgaris were isolated from diabetic wounds. Seventy-six strains had varied multi-drug 
resistance (MDR) pattern encoded on transferable plasmid gene with a very high frequency (2 x10-4 to 4 
x 10-2 per donor cell) by conjugation. 34% of the strains lost the antibiotic resistance plasmids marker 
after sodium dodecyl sulfate (SDS) mediated curing. The rest of the plasmid markers were non 
transferable. The results indicated that plasmids carry varied dissemination of antibiotics resistance 
markers to distant recipient cells, indicating clonal transfer among bacterial strains.    
 
Key words: Resistant, plasmids, Proteus, diabetic, wounds. 
 
 
INTRODUCTION 
 
Diabetic wound lesions are a major medical, social and 
economic problem and are the leading cause of hospi-
talization for patients with diabetes (Ravisekhar et al., 
2006). Diabetes is a disorder in which the pancreas does 
not produce enough insulin for the body need (Frier et al., 
1999; Nelson, 2006). It is one of the world’s major impor-
tant health complications as well as a significant factor in 
the cost of inpatient treatment, lost of lives, disability and 
a reduction in life expectancy (Kumar and Clark, 2002). In 
Nigeria, there are over 10 million diabetic patients, half of 
which are unaware that they do have the disease with the 
highest prevalence > 30 years of age. Diabetic wounds/or 
foot ulcers and infections can lead to amputation of the 
foot or leg and one out 15 diabetic patients requires a 
limb amputation during their lifetime (Frier et al., 1999; 
Unachukwu et al., 2005). According to Motta et al. (2003) 
and Raviskhar et al. (2006) several enterobacteria and 
Gram-positive bacteria have been found to be associated 
with diabetic foot ulcers; therefore this should be a matter  
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of great concern for those who treat and rehabilitate dia-
betic wounds.  
Proteus species are part of the gram-negative bacilli 
found implicated in diabetic wounds along with 
Escherichia, Klebsiella, Enterobacter, and Serratia spe-
cies (Goldstein et al., 1996; Motta et al., 2003; Jun et al., 
2006; Raviskhar et al., 2006). According to the reports of 
Raviskhar et al. (2006) Proteus species are found to be 
most dominant Gram-negative isolates in diabetic 
wounds, followed by Escherichia coli and Pseudomonas 
species whereas Staphylococcus aureus and Enteroco-
ccus species are the most predominant Gram-positive 
isolates from diabetic wounds. Proteus species are found 
in multiple environmental habitats, including long-term 
care facilities and in hospitals. They are easily isolated 
from individuals in long-term care facilities, urinary tract, 
hospitals as well as from patients with underlying 
diseases or compromised immune systems (Louie et al., 
1976; Cheesbrough, 2000). Proteus causes clinically 
significant infections and is often difficult to eradicate 
from the host especially in individuals with complicated 
foot ulcers, catheterization or with functional abnormal-
lities of the urinary tract (Motta et al., 2003; Asad and 
Amna, 2004; Adel et al., 2005; Raviskhar et al., 2006).  
Proteus colonizing the intestinal tract and  wounds vary  
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in their carriage of genes encoding antibiotic resistance 
(Asad and Amna 2004; Yah et al., 2004). However, the 
routine use of antimicrobial agents in both human and 
veterinary medicine has resulted in widespread antibiotic 
resistance and the development of antibiotic resistance 
genes especially within and between the Gram-negative 
bacteria (Ferber, 1998; Enabulele et al., 2006). With the 
presence of antibiotics selective pressure, these resistant 
Proteus species tend to persist, enabling the organism to 
cause extra infections such as septicemia (Prescott et al., 
2001). The overall goal of the study is to determine the 
antibiotic susceptibility profiles of Proteus species from 
diabetic wounds and to assess the potential ability of the 
transferable antibiotics resistant plasmids markers of 
Proteus species from diabetic wounds of diabetes in the 
Ahmadu Bello University Teaching Hospital (ABUTH) 
Zaria, Nigeria. This will enhance the epidemiological stu-
dies, empirical treatment and reduce the risks of diabetic 
wound complications. 
 
 
METHODS 
 
Isolation 
 
A total of 148 Proteus species comprising of 97 Proteus mirabilis 
and 51 Proteus vulgaris were isolated from 168 diabetic wounds of 
diabetes attending ABUTH from 2003 to 2005 to examine their 
susceptibility plasmids profile to antibiotics. Specimens were 
obtained from both out and hospitalized patients. The specimens 
were collected with sterile swabs and inoculated aerobically on 
nutrient agar, blood agar and MacConkey agar (Cheesbrough, 
2000) at 37oC for 24 to 48 h. The bacterial species were identified 
by conventional biochemical tests as described by Cowan and 
Steel (1993). They were further sub-cultured and stored on nutrient 
agar slants at 4oC for further analysis. 
 
 
Antibiotic susceptibility 
 
The antibiotic resistance patterns of the isolates were determined, 
using the disc diffusion method inoculated on Oxoid-Mueller-Hinton 
agar (Difco Laboratories, Detroit, Mich). The inocula were prepared 
directly from an over night agar plates adjusted to 0.5 McFarland 
standard of National Committee for Clinical Laboratory Standards, 
(NCCLS- 2000). The antimicrobial agents tested were ampicillin 
(Am) 30g, gentamicin (Gn) 10g, nalidixic acid (Na) 30g, 
norfloxacin (Nb) 30g, nitrofurantoin (N) 100g, pefloxacin (Pef) 
5g, cotrimoxazole (Co) 50g, cefotaxime (Ce) 5g, ciprofloxacin 
(Cip) 5g, and chloramphenicol (C) 10g. These were aseptically 
placed on the inoculated plates and incubated overnight. The zones 
of inhibition were measured and interpreted according to NCCLS 
(2000).  
 
 
Genetic transfer experiments 
 
The conjugation method was carried according to Wang et al. 
(2004) and Yukata et al. (2004) with E. coli K-12J53-2 (Fr promet) 
Rifr as the recipient. Resistance transfers were selective for by 
using a combination of antibiotics to which the transconjugants 
were resistant but to which the parent strains were sensitive. 
Antibiotic sensitivity tests were then carried out to determine the 
presence of the resistance markers of the donor and the recipient. 
Frequency of transfer was determined by dividing the number of 
transconjugants by the number of donor cells. 
 
 
 
 
Curing experiments 
 
To isolate the cured bacteria, modifications of Olukoya and Oni 
(1990) method was used. This was carried out by treating the cells 
with sodium dodecyl sulfate (SDS). The colonies were then sub-
cultured onto Mueller Hinton agar (Difco Laboratories, Detroit, Mich) 
plates and test run for their respective antibiotic sensitivity patterns 
as previously described. Some of the bacteria were sensitive while 
some were still resistant. Absence of growth on Mueller Hinton agar 
was indicative of plasmids-mediated resistance while growth in 
Mueller Hinton agar was indicative of chromosome-mediated.  
 
 
Plasmids isolation experiments 
 
Plasmids isolation was carried out based on rapid alkaline 
extraction procedures for screening of recombinant plasmid DNA, 
according to Birnboim and Doly (1979) and Zhou et al.  (1990) 
methods. Agarose gel electrophoresis was carried out to resolve 
the extracted plasmids with standard DNA molecular weight marker 
II (0.12-23.1 kbp; bacteriophage lambda HindIII Roche Diagnostic 
GmbH).  
 
 
RESULTS AND DISCUSSION 
 
The study revealed that 156 (92.9%) of the study sub-
jects were males whereas the remaining were females 
(7.1%) with a mean age of 43.86 ± 9.22 years. A total of 
148 Proteus species comprising of 97 P. mirabilis and 51 
Proteus vulgaris were isolated from diabetic wounds of 
diabetes patients attending Ahmadu Bello University 
Teaching Hospital Zaria, Kaduna State, Nigeria as shown 
in Table 1. Apart from Proteus species, other bacterial 
isolates obtained were S. aureus, E. coli, Pseudomonas 
aeruginosa, Klebsiella species and Staphylococcus 
epidermidis. The susceptibility pattern of the Proteus 
species to different antibiotics varied (p<0.05) as shown 
in Table 1a where the isolates were highly resistant to 
ampicillin 60 (40.5%) and least resistant to cefotaxime 15 
(10.1%), ciprofloxacin 9 (6.1%) and pefloxacin 7 (4.7%).  
There was no significant different (P>0.05) between the 
resistant pattern of P. mirabilis and P. vulgaris to the 
various antibiotics. The resistance plasmids against the 
various isolates were very diverse and distributive among 
the Proteus species (Table 2). These plasmids were also 
highly transferable with a high frequency range of 2x10-4 
to 4x10-2. The plasmids bands of the strains ranged from 
0.45kb to 1.25kb (Table 3). Most of the isolates were 
highly mediated by chromosomal resistant (Table 4). 
Forty four percent of the antibiotics were plasmids 
mediated, 32% by chromosome while 24% of the resis-
tant pattern to the antibiotics could not be ascertained. 
The results indicate that the plasmids were able to move 
genetic antibiotics resistance materials among the 
various bacterial strains. 
The rapid emerging of antibiotic resistant transfer 
genes among bacterial population are becoming impor-
tant causes of clinical infections. These bacterial resistant 
genes are more vulnerable in debilitated patients espe-
cially those with immunosuppressed  complications  such  
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Table 1. Occurrence of resistant pathogens from diabetic wounds of diabetes percentage of resistant isolates to antibiotics.  
 
Isolates No. of isolates Am Ce Co N Na Cip Nb Pef Gn C 
P. mirabilis 97 39 (40.2%) 6 (6.2%) 25 (25.8%) 13 (13.4%) 17 (17.5%) 5 (5.2%) 19 (19.6%) 4 (4.1%) 16 (16.5%) 21 (21.6%) 
P. vulgaris 51 21 (41.2%) 9 (17.6%) 13 (33.3%) 15 (29.4%) 12 (23.5%) 4 (7.8%) 9 (17.6%) 3 (5.9%) 10 (19.6%) 17 (33.3%) 
Total 148 60 (40.5%) 15 (10.1%) 38 (25.7%) 38 (25.7%) 29 (19.6%) 9 (6.1%) 28 (18.9% 7 (4.7%) 26 (17.6%) 38 (25.7%) 
 
The values in bracket represent percentage. 
Am = Ampicillin, Cip = Ciprofloxacin, Gn= Gentamicin, Nb = Norfloxacin, C= Chloramphenicol, Na = Nalidixic acid, Co = Cotrimoxazole, Ce = Cefotaxime, N= Nitrofurantoin, Pef = 
Pefloxacin. 
 
 
 
 
 
Table 2. Detection of the frequency of transfer of Proteus species resistant transconjugants markers. 
 
Code Resistant Markers of 
donors (DN) 
EJRifr+ DN Inference Frequency of 
transfer 
Resistant marker of 
transconjugants 
M19 CoNbGnNaCAmN Growth Significant 0.22 x 10-3 Co-N-Am-C 
M3 CoPefNbGnCipNaCAmN Growth Significant 0.13 x 10-1 Gn-N-C 
M4 NaAmNCo Growth Significant 0.25 x 10-1 Am-Na-N 
V5 NbCeCo Growth Significant 0.23 x 10-1 Nb-C-Am 
M18 NaAmNCo Growth Significant 0.23 x 10-2 Am-Nb-Co 
V9 CoGnCipNaCAmNPefNb Growth Significant 0.23 x 10-1 Gn-Na-Am-N 
V20 NaAmNCoCipCe Growth Significant 0.26 x 10-3 Na-Co-N 
V22 NNbGnCipNaCAmPef Growth Significant 0.24 x 10-1 N-Gn-Am-Nb 
M23 GnNaAmNNbCip Growth Significant 0.11 x 10-1 Gn-Na-Nb 
V15 CoGnCipNaAmNNb Growth Significant 0.24 x 10-2 Am-Gn-N 
 
DN = Donor strains of Proteus, EJRifr = E coli rifampicin resistant sucrose negative recipient, M = Proteus mirabilis strains and V = Proteus 
vulgaris strains.  
Am = Ampicillin, Cip = Ciprofloxacin, Gn= Gentamicin, Nb = Norfloxacin, C= Chloramphenicol, Na = Nalidixic acid, Co = Cotrimoxazole, Ce 
= Cefotaxime, N= Nitrofurantoin, Pef = Pefloxacin. 
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Table 3. Antibiotics resistant plasmid profiles of Proteus species transconjugants. 
 
Code of 
isolates 
Resistant Marker 
spectrum of donors (DN) 
Plasmids 
profile (kb) of 
DN 
Plasmids 
transfer(kb) 
transconjugants 
Resistant marker 
Spectrum of 
transconjugants 
TM19 CoNbGnNaCAmN 1.06, 0.77 1.06, 0.77 Co-N-Am-C 
TM3 CoPefNbGnCipNaCAmN 1.25, 0.87 1.25, 0.87 Gn-N-C 
TM4 NaAmNCo 1.25, 0.87 1.25 Am-Na-N 
TV5 NbCeCo 1.25, 0.87, 0.45 1.25 Nb-C 
TM18 NaAmNCo 1.25, 0.87 1.25, 0.87 Am-Nb-Co 
TV9 CoGnCipNaCAmNPefNb 1.06, 0.77 1.06 Gn-Na-Am-N 
TV20 NaAmNCoCipCe 1.25, 0.87 1.25, 0.87 Na-Co-N 
TV22 NNbGnCipNaCAmPef 1.25, 0.87,0.45 1.25, 0.87 N-Gn-Am-Nb 
TM23 GnNaAmNNbCip 1.25, 0.87,0.45 1.25, 0.87 Gn-Na-Nb 
TV15 CoGnCipNaAmNNb 1.06, 0.77 1.06, 0.77 Am-Co-N 
 
TM = Proteus mirabilis transconjugants, DN = donor strains, TV = Proteus vulgaris transconjugants.  
Am = Ampicillin, Cip = Ciprofloxacin, Gn= Gentamicin, Nb = Norfloxacin, C= Chloramphenicol, Na = Nalidixic acid, Co = 
Cotrimoxazole, Ce = Cefotaxime, N= Nitrofurantoin, Pef = Pefloxacin. 
 
 
 
Table 4. Chromosomally mediated antibiotic resistant markers of Proteus species.  
 
Code of isolates Resistant spectrum before 
curing (wthout SDS) 
Resistant spectrum after curing 
(treatment wth SDS) 
CM19 CoGnNaCAmN Na-C-Am-Gn 
CM3 CoGnNaCAmN - 
CM4 NaAmNCo Co-Am-N 
CV5 NbCeCo Nb-Co 
CM8 GnCCo C-Gn 
CV9 CoGnCipNaCAmNPefNb Co-Pef-Na 
CV10 NNbCoNaCAm Nb-Co-Na-C 
CV20 NaAmNCoCipCe Cip 
CM22 NNbGnCipNaCAmPef C 
CV15 CoGnCipNaAmNNb N-Nb 
CV18 NaAmN - 
 
CM = Chromosomally cured resistant Proteus mirabilis, CV = chromosomally cured resistant Proteus 
vulgaris, SDS = Sodium dodecyl sulfate. 
Am = Ampicillin, Cip = Ciprofloxacin, Gn= Gentamicin, Nb = Norfloxacin, C= Chloramphenicol, Na = 
Nalidixic acid, Co = Cotrimoxazole, Ce = Cefotaxime, N= Nitrofurantoin, Pef = Pefloxacin. 
 
 
 
as HIV/AIDS, cancers, diabetic wounds, burns, etc (Frier 
et al., 1999; Prescott et al., 2001). It is often very impor-
tant to be able to compare strains of different species 
obtained from these patients as this may be very useful in 
epidemiological studies especially when disease out-
break has occurred (Prescott et al., 2001). In the current 
study, antibiotics resistant profiles of Proteus species 
from diabetic wounds were studied. The results indicated 
that Proteus species harbors a wide range of varied 
molecular weights antibiotic resistant plasmids ( 23.1 
kb). Out of a total 148 Proteus species, 76 (51.4%) had 
varied multi-drug resistant markers, of which some are 
encoded on transferable plasmids. The frequency of 
transfer of the resistant plasmids ranged from 2x10-4 to 
4x10-2 per donor cells. It was therefore evident that anti-
biotics resistant plasmids markers among Proteus spe-
cies could easily be transferred by conjugation. This is 
because the resistant patterns of the transconjugants 
were similar to the resistant pattern of the donor cells.  
The positive transconjugant electrophoretic pattern also 
revealed plasmids showing approximate relative distanc-
es, sizes and molecular weights similar to their respective 
parent donor cells ( 23.1kb). This high frequency of 
transfer coincided with those of Yukata et al. (2004) that 
ranged from 2x10-4 to 6x10-1 per donor cells while 
characterizing conjugation experiment of E. coli  produc-
ing CTX-M-2 -lactamase in Japanese cattle. Also Wang 
et al.  (2004)  while  detecting  plasmids-mediated  quino- 
  
 
 
 
lones resistant markers of Klebsiella pneumoniae in the 
United States selected seven quinolones positive donor 
cells with sulfamethoxazole at a high frequency of 2x10-4 
to 8x10-4 per donor cells. The present study also showed 
that Proteus species harbors highly transferable resistant 
plasmids markers to ampicillin, followed by nitrofurantoin, 
gentamicin, nalidixic acid and norfloxacin. None of the 
Proteus species had plasmids resistant transferred mar-
kers of ciprofloxacin, pefloxacin and cefotaxime.  
In the studies of Yukata et al. (2004), all the isolates 
were able to transfer cefotaxime resistance to the reci-
pient cell which deviated from the current studies where 
some of the species lack discernible resistant transfer 
markers. In the work of Wang et al. (2004) all the isolates 
were resistant to ampicillin and were encoded on trans-
ferable plasmids as well as in their transconjugants. 
These transferable resistance markers between different 
bacterial isolates may go unnoticed by infection control 
methods, therefore undermining hospital infections con-
trol policies (Nashwan et al., 2005). The result also indi-
cated that there was no correlation between the number 
of antibiotics that a plasmid mediates to and its size. 
Although other findings have reported plasmids mediated 
resistance with similar genetic backbone sharing similar 
resistant profiles (Miranda et al., 2004). In the current 
study, plasmids with the same relative distance on elec-
trophoresis, size and molecular weights had varied anti-
biotic resistance patterns.  
Apart from Proteus species, widespread drug resis-
tance plasmids mediated genes have been widely 
reported in E. coli, Salmonella, Shigella, Klebsiella and 
Staphylococcus (Motta et al., 2003; Po-Ren et al., 2004). 
Although it has been reported that most plasmids acquire 
their antibiotic resistance genes through transposons, 
chromosomes or from other plasmids (Norma et al., 
2004), it is necessary to elaborate and enhance ways of 
controlling these phenomenon. 
The current study also shows that the in vitro analysis 
challenging transfer experiments was the inability of 
plasmids reception by the standard strain and the rate at 
which the plasmids are lost during samples analysis. It 
was observed that successive sub-cultures of the Proteus 
species resulted in rapid lost of the plasmids than from 
freshly analyzed diabetic wound samples. The incidence 
of plasmids was also higher in freshly cultured diabetic 
wound sample isolates than in old stored cultured 
diabetic wound samples.  
From the curing experiments, sodium dodecyl sulfate 
(SDS) was found to eliminate plasmids from the bacteria 
cells. The inability of some of the Proteus species to 
exhibit particular resistant pattern after curing indicated 
that resistance to some antibiotics were plasmids or 
chromosome mediated or both plasmids and chromo-
some mediated. Enabulele et al. (1993) reported that 
13.6% of gram-negative bacteria isolated from infected 
wounds from the University Benin Teaching Hospital 
were plasmids mediated after curing. Plasmids can also  
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be lost through successive sub-cultures (Prescott et al., 
2003). Ethidium bromide has also been reported as a 
good curing reagent of plasmids from cells. After curing, 
the cells were lysed and separated electrophoretically as 
previously described by Meyers et al. (1976). Most of the 
separated electrophoretic DNA bands had only the 
chromosomal molecular weight > 23.1kb without/or with 
large plasmids DNA bands.  
In developing countries, however, antibiotic resistance 
is highly linked to inappropriate use of antibiotics, lack of 
health care personnel with continual health education on 
antibiotics and poor quality drugs. Therefore, continual 
surveillance of antibiotic resistance in developing coun-
tries is important to alleviate morbidity and mortality rate 
of various microbial infections.  
The sizes of the plasmids varied and resistance mark-
ers showed that there was no plasmid epidemic involved 
in the antibiotic resistance against Proteus species. 
Unfortunately, resistance among enterobacteria isolates 
has become increasingly common, making empirical 
treatment more difficult based on antibiotic resistant plas-
mids. Proteus species are being isolated at an increasing 
rate in hospital settings and are having a significant 
impact on clinical practice and treatment cost. According 
to Miranda et al. (2004), these clinically derived plasmids 
do not belong to distinct plasmid lineages but exhibit 
evidence of broad scale inter-plasmid gene transfer 
probably involving a range of mechanisms such as 
recombination, transposition and integration.  
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